कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium) - tablet - 10mg; 80mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium) 80mg - hmg-coa reductase inhibitors

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - pregabalin - capsule - 225mg - pregabalin 225mg - miscellaneous anticonvulsants

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - naproxen; esomeprazole (esomeprazole magnesium) - tablet (immediate and delayed-release) - 500mg; 20mg - naproxen 500mg; esomeprazole (esomeprazole magnesium) 20mg - other nonsteroidal antiimflammatory agents

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - naproxen; esomeprazole (esomeprazole magnesium) - tablet (immediate and delayed-release) - 375mg; 20mg - naproxen 375mg; esomeprazole (esomeprazole magnesium) 20mg - other nonsteroidal antiimflammatory agents

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - atorvastatin (atorvastatin calcium) - tablet - 10mg - atorvastatin (atorvastatin calcium) 10mg - hmg-coa reductase inhibitors

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - atorvastatin (atorvastatin calcium) - tablet - 20mg - atorvastatin (atorvastatin calcium) 20mg - hmg-coa reductase inhibitors

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - atorvastatin (atorvastatin calcium) - tablet - 40mg - atorvastatin (atorvastatin calcium) 40mg - hmg-coa reductase inhibitors

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - atorvastatin (atorvastatin calcium) - tablet - 80mg - atorvastatin (atorvastatin calcium) 80mg - hmg-coa reductase inhibitors

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

mylan s.a.s - ritonavir - hiv infections - antivirals for systemic use - ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infected patients (adults and children of 2 years of age and older).

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.